Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 0.02
ACHC's Cash-to-Debt is ranked lower than
97% of the 274 Companies
in the Global Medical Care industry.

( Industry Median: 0.28 vs. ACHC: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
ACHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: 0.49
Current: 0.02
0
0.49
Equity-to-Asset 0.41
ACHC's Equity-to-Asset is ranked lower than
65% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 0.48 vs. ACHC: 0.41 )
Ranked among companies with meaningful Equity-to-Asset only.
ACHC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.22  Med: 0.39 Max: 0.56
Current: 0.41
0.22
0.56
Debt-to-Equity 1.20
ACHC's Debt-to-Equity is ranked lower than
77% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 0.64 vs. ACHC: 1.20 )
Ranked among companies with meaningful Debt-to-Equity only.
ACHC' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.63  Med: 1.3 Max: 3.05
Current: 1.2
0.63
3.05
Debt-to-EBITDA 5.73
ACHC's Debt-to-EBITDA is ranked lower than
79% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 2.81 vs. ACHC: 5.73 )
Ranked among companies with meaningful Debt-to-EBITDA only.
ACHC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -11.1  Med: 5.82 Max: 6.71
Current: 5.73
-11.1
6.71
Interest Coverage 2.33
ACHC's Interest Coverage is ranked lower than
80% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 6.85 vs. ACHC: 2.33 )
Ranked among companies with meaningful Interest Coverage only.
ACHC' s Interest Coverage Range Over the Past 10 Years
Min: 2.1  Med: 2.66 Max: 10.7
Current: 2.33
2.1
10.7
Piotroski F-Score: 7
Altman Z-Score: 1.32
Beneish M-Score: -2.45
WACC vs ROIC
4.30%
6.68%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.37
ACHC's Operating Margin % is ranked higher than
73% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 6.83 vs. ACHC: 14.37 )
Ranked among companies with meaningful Operating Margin % only.
ACHC' s Operating Margin % Range Over the Past 10 Years
Min: -13.52  Med: 14.97 Max: 16.24
Current: 14.37
-13.52
16.24
Net Margin % 7.44
ACHC's Net Margin % is ranked higher than
65% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 3.88 vs. ACHC: 7.44 )
Ranked among companies with meaningful Net Margin % only.
ACHC' s Net Margin % Range Over the Past 10 Years
Min: -16.12  Med: 6.12 Max: 10
Current: 7.44
-16.12
10
ROE % 8.72
ACHC's ROE % is ranked higher than
51% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 8.03 vs. ACHC: 8.72 )
Ranked among companies with meaningful ROE % only.
ACHC' s ROE % Range Over the Past 10 Years
Min: -72.42  Med: 8.43 Max: 12.2
Current: 8.72
-72.42
12.2
ROA % 3.41
ACHC's ROA % is ranked lower than
52% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.48 vs. ACHC: 3.41 )
Ranked among companies with meaningful ROA % only.
ACHC' s ROA % Range Over the Past 10 Years
Min: -16.9  Med: 3.21 Max: 4.84
Current: 3.41
-16.9
4.84
ROC (Joel Greenblatt) % 14.00
ACHC's ROC (Joel Greenblatt) % is ranked lower than
52% of the 272 Companies
in the Global Medical Care industry.

( Industry Median: 14.91 vs. ACHC: 14.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ACHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -58.23  Med: 20.23 Max: 35.04
Current: 14
-58.23
35.04
3-Year Revenue Growth Rate 21.50
ACHC's 3-Year Revenue Growth Rate is ranked higher than
89% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 6.50 vs. ACHC: 21.50 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ACHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 21.5 Max: 35.6
Current: 21.5
0
35.6
3-Year EBITDA Growth Rate 22.60
ACHC's 3-Year EBITDA Growth Rate is ranked higher than
83% of the 184 Companies
in the Global Medical Care industry.

( Industry Median: 5.90 vs. ACHC: 22.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ACHC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 22.6 Max: 40.7
Current: 22.6
0
40.7
3-Year EPS without NRI Growth Rate 15.30
ACHC's 3-Year EPS without NRI Growth Rate is ranked higher than
63% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. ACHC: 15.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ACHC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -56.7 Max: 45.7
Current: 15.3
0
45.7
GuruFocus has detected 3 Warning Signs with Acadia Healthcare Co Inc ACHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ACHC's 30-Y Financials

Financials (Next Earnings Date: 2018-07-27 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2017

ACHC Guru Trades in Q2 2017

Vanguard Health Care Fund 3,698,655 sh (unchged)
Richard Snow 25,000 sh (unchged)
Pioneer Investments Sold Out
Jim Simons Sold Out
Andreas Halvorsen Sold Out
Manning & Napier Advisors, Inc Sold Out
Paul Tudor Jones Sold Out
Chuck Royce 98,026 sh (-2.00%)
Alan Fournier 1,328,735 sh (-29.14%)
Steven Cohen 562,300 sh (-48.18%)
Joel Greenblatt 167,007 sh (-78.85%)
» More
Q3 2017

ACHC Guru Trades in Q3 2017

Ken Fisher 204,996 sh (New)
Alan Fournier 1,610,790 sh (+21.23%)
Richard Snow 25,000 sh (unchged)
Vanguard Health Care Fund 3,698,655 sh (unchged)
Chuck Royce 96,026 sh (-2.04%)
Joel Greenblatt 137,206 sh (-17.84%)
Steven Cohen 191,761 sh (-65.90%)
» More
Q4 2017

ACHC Guru Trades in Q4 2017

Chuck Royce 258,526 sh (+169.23%)
Vanguard Health Care Fund 4,601,355 sh (+24.41%)
Richard Snow Sold Out
Steven Cohen Sold Out
Joel Greenblatt Sold Out
Ken Fisher 202,100 sh (-1.41%)
Alan Fournier 1,283,514 sh (-20.32%)
» More
Q1 2018

ACHC Guru Trades in Q1 2018

Lee Ainslie 31,100 sh (New)
Steven Cohen 420,500 sh (New)
Chuck Royce 293,526 sh (+13.54%)
Vanguard Health Care Fund 4,601,355 sh (unchged)
Alan Fournier Sold Out
Ken Fisher 198,875 sh (-1.60%)
» More
» Details

Insider Trades

Latest Guru Trades with ACHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ken Fisher 2018-03-31 Reduce -1.60%$32.39 - $42 $ 42.3015%198,875
Vanguard Health Care Fund 2017-12-31 Add 24.41%0.06%$27.79 - $47.61 $ 42.3022%4,601,355
Ken Fisher 2017-12-31 Reduce -1.41%$27.79 - $47.61 $ 42.3022%202,100
Joel Greenblatt 2017-12-31 Sold Out 0.1%$27.79 - $47.61 $ 42.3022%0
Ken Fisher 2017-09-30 New Buy0.01%$44.84 - $53 $ 42.30-13%204,996
Joel Greenblatt 2017-09-30 Reduce -17.84%0.02%$44.84 - $53 $ 42.30-13%137,206
Joel Greenblatt 2017-06-30 Reduce -78.85%0.35%$41.31 - $49.6 $ 42.30-4%167,007
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:AMN, ASX:HSO, JSE:NTC, JSE:LHC, XSGO:BANMEDICA, NYSE:THC, SAU:4002, NYSE:SEM, NAS:LHCG, NAS:AMED, NSE:APOLLOHOSP, XTER:RHK, NYSE:MD, ISX:MIKA, NAS:LPNT, BKK:BH, NYSE:EVHC, TSE:7716, HKSE:01515, OSTO:ATT » details
Traded in other countries:7RA.Germany,
Headquarter Location:USA
Acadia Healthcare Co Inc operates mental healthcare facilities in the United States. It addresses behavioral abnormalities in psychiatric facilities, substance abuse facilities, and residential treatment centers.

Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the largest proportion of payments from Medicaid, with the second largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.

Top Ranked Articles about Acadia Healthcare Co Inc

New Research: Key Drivers of Growth for Harley-Davidson, BioMarin Pharmaceutical, Acadia Healthcare, Parker Drilling, NCR, and New York Community — Factors of Influence, Major Initiatives and Sustained Production
FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Acadia Healthcare Company, Inc. (Nasdaq:ACHC) To Contact The Firm
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
ACADIA HEALTHCARE SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
Lifshitz & Miller LLP Announces Investigation of Acadia Healthcare Company, Inc., Akorn, Inc., Blackhawk Network Holdings, Inc., Facebook, Inc., IZEA Inc., MuleSoft, Inc., Solid Biosciences Inc., and Tableau Software, Inc.
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
Acadia Healthcare Announces Date for First Quarter 2018 Earnings Release
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Acadia Healthcare Company, Inc. (Nasdaq: ACHC) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
ACADIA HEALTHCARE SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Acadia Healthcare Company, Inc. - ACHC
Bernstein Liebhard LLP Announces That A Class Action Has Been Filed On Behalf Of Acadia Healthcare Company, Inc. Investors

Ratios

vs
industry
vs
history
PE Ratio 17.17
ACHC's PE Ratio is ranked higher than
75% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 27.31 vs. ACHC: 17.17 )
Ranked among companies with meaningful PE Ratio only.
ACHC' s PE Ratio Range Over the Past 10 Years
Min: 13.86  Med: 46.12 Max: 575.78
Current: 17.17
13.86
575.78
Forward PE Ratio 16.08
ACHC's Forward PE Ratio is ranked higher than
76% of the 59 Companies
in the Global Medical Care industry.

( Industry Median: 20.66 vs. ACHC: 16.08 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.17
ACHC's PE Ratio without NRI is ranked higher than
76% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. ACHC: 17.17 )
Ranked among companies with meaningful PE Ratio without NRI only.
ACHC' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.86  Med: 45.59 Max: 575.78
Current: 17.17
13.86
575.78
Price-to-Owner-Earnings 24.35
ACHC's Price-to-Owner-Earnings is ranked higher than
53% of the 109 Companies
in the Global Medical Care industry.

( Industry Median: 26.64 vs. ACHC: 24.35 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ACHC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 19.29  Med: 35.75 Max: 88.8
Current: 24.35
19.29
88.8
PB Ratio 1.41
ACHC's PB Ratio is ranked higher than
77% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 2.64 vs. ACHC: 1.41 )
Ranked among companies with meaningful PB Ratio only.
ACHC' s PB Ratio Range Over the Past 10 Years
Min: 0.99  Med: 3.07 Max: 5.75
Current: 1.41
0.99
5.75
PS Ratio 1.29
ACHC's PS Ratio is ranked higher than
62% of the 262 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. ACHC: 1.29 )
Ranked among companies with meaningful PS Ratio only.
ACHC' s PS Ratio Range Over the Past 10 Years
Min: 0.7  Med: 2.1 Max: 3.74
Current: 1.29
0.7
3.74
Price-to-Free-Cash-Flow 47.15
ACHC's Price-to-Free-Cash-Flow is ranked lower than
70% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 23.01 vs. ACHC: 47.15 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ACHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 28.75  Med: 47.36 Max: 356.67
Current: 47.15
28.75
356.67
Price-to-Operating-Cash-Flow 8.86
ACHC's Price-to-Operating-Cash-Flow is ranked higher than
70% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 14.67 vs. ACHC: 8.86 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ACHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.6  Med: 25.89 Max: 47.87
Current: 8.86
6.6
47.87
EV-to-EBIT 16.68
ACHC's EV-to-EBIT is ranked higher than
68% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 21.68 vs. ACHC: 16.68 )
Ranked among companies with meaningful EV-to-EBIT only.
ACHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -53.3  Med: 24.1 Max: 49.7
Current: 16.68
-53.3
49.7
EV-to-EBITDA 12.28
ACHC's EV-to-EBITDA is ranked higher than
65% of the 228 Companies
in the Global Medical Care industry.

( Industry Median: 15.23 vs. ACHC: 12.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
ACHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -80.5  Med: 20.6 Max: 38.2
Current: 12.28
-80.5
38.2
EV-to-Revenue 2.42
ACHC's EV-to-Revenue is ranked lower than
53% of the 271 Companies
in the Global Medical Care industry.

( Industry Median: 2.17 vs. ACHC: 2.42 )
Ranked among companies with meaningful EV-to-Revenue only.
ACHC' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.8  Med: 3.6 Max: 5.7
Current: 2.42
1.8
5.7
PEG Ratio 0.53
ACHC's PEG Ratio is ranked higher than
91% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 3.13 vs. ACHC: 0.53 )
Ranked among companies with meaningful PEG Ratio only.
ACHC' s PEG Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.55 Max: 10.74
Current: 0.53
0.35
10.74
Current Ratio 1.29
ACHC's Current Ratio is ranked lower than
56% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. ACHC: 1.29 )
Ranked among companies with meaningful Current Ratio only.
ACHC' s Current Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.36 Max: 4.38
Current: 1.29
0.93
4.38
Quick Ratio 1.28
ACHC's Quick Ratio is ranked higher than
50% of the 260 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. ACHC: 1.28 )
Ranked among companies with meaningful Quick Ratio only.
ACHC' s Quick Ratio Range Over the Past 10 Years
Min: 0.93  Med: 1.35 Max: 4.38
Current: 1.28
0.93
4.38
Days Sales Outstanding 40.93
ACHC's Days Sales Outstanding is ranked higher than
52% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 39.87 vs. ACHC: 40.93 )
Ranked among companies with meaningful Days Sales Outstanding only.
ACHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.19  Med: 44.06 Max: 59.22
Current: 40.93
34.19
59.22

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -13.70
ACHC's 3-Year Average Share Buyback Ratio is ranked lower than
82% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. ACHC: -13.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ACHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -22.6  Med: -13.7 Max: 0
Current: -13.7
-22.6
0

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.81
ACHC's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
56% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. ACHC: 1.81 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ACHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.46  Med: 2.56 Max: 3.35
Current: 1.81
1.46
3.35
Price-to-Median-PS-Value 0.61
ACHC's Price-to-Median-PS-Value is ranked higher than
89% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. ACHC: 0.61 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ACHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.42  Med: 1.03 Max: 1.71
Current: 0.61
0.42
1.71
Price-to-Peter-Lynch-Fair-Value 0.69
ACHC's Price-to-Peter-Lynch-Fair-Value is ranked higher than
93% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 2.08 vs. ACHC: 0.69 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ACHC' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.57  Med: 0.8 Max: 19.75
Current: 0.69
0.57
19.75
Earnings Yield (Greenblatt) % 6.01
ACHC's Earnings Yield (Greenblatt) % is ranked higher than
75% of the 273 Companies
in the Global Medical Care industry.

( Industry Median: 3.61 vs. ACHC: 6.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ACHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -7.4  Med: 3.9 Max: 7.1
Current: 6.01
-7.4
7.1
Forward Rate of Return (Yacktman) % 19.74
ACHC's Forward Rate of Return (Yacktman) % is ranked higher than
83% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 9.10 vs. ACHC: 19.74 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ACHC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 18.8  Med: 19.6 Max: 19.8
Current: 19.74
18.8
19.8

More Statistics

Revenue (TTM) (Mil) $2,899.36
EPS (TTM) $ 2.47
Beta0.49
Volatility48.55%
52-Week Range $26.92 - 54.34
Shares Outstanding (Mil)88.24

Analyst Estimate

Dec18 Dec19 Dec20
Revenue (Mil $) 3,064 3,263 3,466
EBIT (Mil $) 480 516 552
EBITDA (Mil $) 641 692 738
EPS ($) 2.60 2.90 3.22
EPS without NRI ($) 2.60 2.90 3.22
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 77
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}